← Back

Lauxera Capital Partners and Accelmed Partners Invests in Veranex

05.19.2022

Veranex serves the medical technology industry by providing design, engineering, regulatory, preclinical research, clinical development, commercial strategy, and market access services on an integrated basis. As a result, Veranex helps companies accelerate their speed to market while mitigating the cost and risk of MedTech product development. Since the company's formation in 2021, Veranex has completed six acquisitions to build its position as the leading global product development services provider dedicated to the medical device and biotech space.

The Premium Lower and Middle Market M&A Platform

For full transactional data, join PrivSource today!

Apply →